Nephros (NEPH) Common Equity (2010 - 2026)
Nephros (NEPH) posted quarterly Common Equity of $10.7 million for Q1 2026, up 15.18% year-over-year from $9.3 million in Q1 2025, and up 4.89% quarter-over-quarter from $10.2 million in Q4 2025.
Nephros (NEPH) Common Equity (2010 - 2026) Analysis & Trends
Nephros' Common Equity history runs 17 years deep, the most recent figure standing at $10.7 million for Q1 2026.
- In Q1 2026, Common Equity rose 15.18% year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $10.7 million (up 15.18% YoY), while the FY2025 annual figure was $10.2 million, up 18.84% from the prior year.
- Common Equity for Q1 2026 stood at $10.7 million, up from $10.2 million in the prior quarter.
- The five-year high for Common Equity was $13.4 million in Q1 2022, with the low at $7.9 million in Q2 2024.
- The 5-year median for Common Equity is $8.9 million (2023), against an average of $9.5 million.
- The sharpest annual moves came in 2022 and 2025: Common Equity plunged 39.79% in 2022, then grew 22.41% in 2025.
- Nephros' Common Equity stood at $8.9 million in 2022, then fell by 5.89% to $8.4 million in 2023, then rose by 2.72% to $8.6 million in 2024, then gained by 18.84% to $10.2 million in 2025, then increased by 4.89% to $10.7 million in 2026.
- Business Quant data shows NEPH's Common Equity at $10.7 million in Q1 2026, $10.2 million in Q4 2025, and $10.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 11.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.97 Mn |
| Mar 31, 2026 | 10.70 Mn |
| Dec 31, 2025 | 10.20 Mn |
| Sep 30, 2025 | 10.01 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | 9.29 Mn |
| Dec 31, 2024 | 8.59 Mn |
| Sep 30, 2024 | 8.17 Mn |
| Jun 30, 2024 | 7.93 Mn |
| Mar 31, 2024 | 8.18 Mn |
| Dec 31, 2023 | 8.36 Mn |
| Sep 30, 2023 | 8.62 Mn |
| Jun 30, 2023 | 8.66 Mn |
| Mar 31, 2023 | 8.89 Mn |
| Dec 31, 2022 | 8.88 Mn |
| Sep 30, 2022 | 9.58 Mn |
| Jun 30, 2022 | 12.48 Mn |
| Mar 31, 2022 | 13.40 Mn |
| Dec 31, 2021 | 14.75 Mn |
| Sep 30, 2021 | 15.33 Mn |